NW Bio enters $4.9M convertible note financing with Yorkville; also secures $50M standby equity facility

NORTHWEST BIOTHERAPEUTICS INC

$4.9M convertible promissory note, 12-month term, no interest, 5% OID, convertible at discount to market.
Yorkville also acquired warrant to purchase up to $2M shares at $0.205 per share.
Standby equity subscription agreement for up to $50M in common shares, available after note repaid/converted, 24-month term.
Proceeds for general corporate purposes including lead product and in-licensed portfolios.
Prior standby equity subscription agreement cancelled.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.